← Browse by Condition

Medical Condition

dementia

Total Trials

23

Recruiting Now

23

Trial Phases

Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for dementia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — dementia Clinical Trials

How many clinical trials are currently recruiting for dementia?

ClinicalMetric currently tracks 23 actively recruiting clinical trials for dementia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 23. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for dementia?

dementia research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a dementia clinical trial?

Eligibility criteria for dementia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

1

Phase 2

1

Top Sponsors

University of Cambridge 1 trial

Universitätsklinikum Hamburg-Eppendorf 1 trial

University College, London 1 trial

German Center for Neurodegenerative Diseases (DZNE) 1 trial

Lancashire Teaching Hospitals NHS Foundation Trust 1 trial

Recruiting Clinical Trials

The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions

University of Cambridge

Hamburg City Health Study - a German Cohort Study

Universitätsklinikum Hamburg-E...

BELIDE: Better Living With Non-memory-led Dementia

University College, London

Dyadic, App-supported Collaborative Care Intervention Trial for Family Caregivers of People Living With Dementia

German Center for Neurodegener...

Neurofrailty: A Study of Late-onset Epilepsy and Its Associations

Lancashire Teaching Hospitals ...

Biobank and Brain Health in Bordeaux.

University Hospital, Bordeaux

Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family Caregivers

The University of Hong Kong

Clinical Applications of Advanced Ophthalmic Imaging

University of Miami

A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia

University of Campania Luigi V...

NCT07012993 Phase 2

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

NCT04396873 Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

National Institute of Mental H...

Effect of Cognitive Empathy Training on Dementia Caregivers

Emory University

ADRC Clinical Cohort (Alzheimer's Disease)

Duke University

Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons

Kessler Foundation

The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia

University of Alabama at Birmi...

HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population

Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices

IRCCS Centro Neurolesi Bonino ...

Environmental and Sensory Intervention for Nursing Home Residents With Dementia Who Exhibit Persistent Vocalizations

Drexel University

CUHK Brain Health Longitudinal Study

Chinese University of Hong Kon...

Fostering Positive Care Interactions in Assisted Living

University of Maryland, Baltim...

Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression

IRCCS San Raffaele

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

University of Alabama, Tuscalo...

Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan

The Neurology Center of Southe...

Related Conditions

alzheimer disease (10) mild cognitive impairment (7) stroke (4) alzheimer s disease (3) parkinson disease (2) parkinson s disease (2) mild cognitive impairment mci (2) dementia alzheimers (2) cognition (2) brain diseases (2) multiple sclerosis (2) subjective cognitive decline (2)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology